Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246077
Status:
COMPLETED
Last Update Posted:
2007-04-11
First Post:
2005-10-27
Brief Title:
Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a Lifeport
Sponsor:
Childrens Mercy Hospital Kansas City
Organization:
Childrens Mercy Hospital Kansas City
Study Overview
Official Title:
Quality of Life of Children With Sickle Cell Disease Who Are Receiving Chronic Transfusion Therapy With a Lifeport Device
Status:
COMPLETED
Status Verified Date:
2005-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to see what impact having a Lifeport device has on quality of life for children with sickle cell who are getting chronic transfusions from the childs perspective
Detailed Description:
There is a paucity of research that focuses specifically on quality of life QoL among patients with sickle cell This study aims to explore the QoL of children who are receiving chronic transfusion therapy CTT using a Lifeport device which allows them to undergo erythrocytapheresis rather than standard transfusion therapy Erythrocytapheresis is less time consuming and is associated with less iron overload than conventional transfusion therapy however little is known about the implications for the childs QoL This study will explore QoL from the childs perspective
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None